Stock Analysis on Net

Walgreens Boots Alliance Inc. (NASDAQ:WBA)

This company has been moved to the archive! The financial data has not been updated since July 9, 2020.

Analysis of Reportable Segments

Microsoft Excel

Segment Profit Margin

Walgreens Boots Alliance Inc., profit margin by reportable segment

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Retail Pharmacy USA 5.03% 5.91% 6.42% 6.39% 6.30% 6.37%
Retail Pharmacy International 6.52% 7.56% 7.95% 8.71% 7.02%
Pharmaceutical Wholesale 4.07% 4.07% 4.35% 3.14% 2.94%

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).

Segment profitability ratio Reportable segment The company
Segment profit margin Retail Pharmacy USA Retail Pharmacy USA segment profit margin ratio deteriorated from 2017 to 2018 and from 2018 to 2019.
Retail Pharmacy International Retail Pharmacy International segment profit margin ratio deteriorated from 2017 to 2018 and from 2018 to 2019.
Pharmaceutical Wholesale Pharmaceutical Wholesale segment profit margin ratio deteriorated from 2017 to 2018 but then slightly improved from 2018 to 2019.

Segment Profit Margin: Retail Pharmacy USA

Walgreens Boots Alliance Inc.; Retail Pharmacy USA; segment profit margin calculation

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Selected Financial Data (US$ in millions)
Adjusted operating income 5,255 5,814 5,606 5,357 5,098 4,866
Sales 104,532 98,392 87,302 83,802 80,974 76,392
Segment Profitability Ratio
Segment profit margin1 5.03% 5.91% 6.42% 6.39% 6.30% 6.37%

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).

1 2019 Calculation
Segment profit margin = 100 × Adjusted operating income ÷ Sales
= 100 × 5,255 ÷ 104,532 = 5.03%

Segment profitability ratio Reportable segment The company
Segment profit margin Retail Pharmacy USA Retail Pharmacy USA segment profit margin ratio deteriorated from 2017 to 2018 and from 2018 to 2019.

Segment Profit Margin: Retail Pharmacy International

Walgreens Boots Alliance Inc.; Retail Pharmacy International; segment profit margin calculation

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Selected Financial Data (US$ in millions)
Adjusted operating income 747 929 939 1,155 616
Sales 11,462 12,281 11,813 13,256 8,781
Segment Profitability Ratio
Segment profit margin1 6.52% 7.56% 7.95% 8.71% 7.02%

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).

1 2019 Calculation
Segment profit margin = 100 × Adjusted operating income ÷ Sales
= 100 × 747 ÷ 11,462 = 6.52%

Segment profitability ratio Reportable segment The company
Segment profit margin Retail Pharmacy International Retail Pharmacy International segment profit margin ratio deteriorated from 2017 to 2018 and from 2018 to 2019.

Segment Profit Margin: Pharmaceutical Wholesale

Walgreens Boots Alliance Inc.; Pharmaceutical Wholesale; segment profit margin calculation

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Selected Financial Data (US$ in millions)
Adjusted operating income 939 936 922 708 450
Sales 23,053 23,006 21,188 22,571 15,327
Segment Profitability Ratio
Segment profit margin1 4.07% 4.07% 4.35% 3.14% 2.94%

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).

1 2019 Calculation
Segment profit margin = 100 × Adjusted operating income ÷ Sales
= 100 × 939 ÷ 23,053 = 4.07%

Segment profitability ratio Reportable segment The company
Segment profit margin Pharmaceutical Wholesale Pharmaceutical Wholesale segment profit margin ratio deteriorated from 2017 to 2018 but then slightly improved from 2018 to 2019.

Segment Capital Expenditures to Depreciation

Walgreens Boots Alliance Inc., capital expenditures to depreciation by reportable segment

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Retail Pharmacy USA 0.91 0.85 0.79 0.69 0.78 0.84
Retail Pharmacy International 0.64 0.58 0.93 1.11 0.63
Pharmaceutical Wholesale 0.69 0.67 0.71 0.63 0.43

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Retail Pharmacy USA Retail Pharmacy USA segment capital expenditures to depreciation ratio improved from 2017 to 2018 and from 2018 to 2019.
Retail Pharmacy International Retail Pharmacy International segment capital expenditures to depreciation ratio deteriorated from 2017 to 2018 but then slightly improved from 2018 to 2019.
Pharmaceutical Wholesale Pharmaceutical Wholesale segment capital expenditures to depreciation ratio deteriorated from 2017 to 2018 but then improved from 2018 to 2019 not reaching 2017 level.

Segment Capital Expenditures to Depreciation: Retail Pharmacy USA

Walgreens Boots Alliance Inc.; Retail Pharmacy USA; segment capital expenditures to depreciation calculation

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Selected Financial Data (US$ in millions)
Capital expenditures 1,323 1,022 860 777 951 1,106
Depreciation and amortization 1,459 1,196 1,090 1,134 1,217 1,316
Segment Financial Ratio
Segment capital expenditures to depreciation1 0.91 0.85 0.79 0.69 0.78 0.84

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).

1 2019 Calculation
Segment capital expenditures to depreciation = Capital expenditures ÷ Depreciation and amortization
= 1,323 ÷ 1,459 = 0.91

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Retail Pharmacy USA Retail Pharmacy USA segment capital expenditures to depreciation ratio improved from 2017 to 2018 and from 2018 to 2019.

Segment Capital Expenditures to Depreciation: Retail Pharmacy International

Walgreens Boots Alliance Inc.; Retail Pharmacy International; segment capital expenditures to depreciation calculation

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Selected Financial Data (US$ in millions)
Capital expenditures 275 241 384 444 249
Depreciation and amortization 429 419 414 401 393
Segment Financial Ratio
Segment capital expenditures to depreciation1 0.64 0.58 0.93 1.11 0.63

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).

1 2019 Calculation
Segment capital expenditures to depreciation = Capital expenditures ÷ Depreciation and amortization
= 275 ÷ 429 = 0.64

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Retail Pharmacy International Retail Pharmacy International segment capital expenditures to depreciation ratio deteriorated from 2017 to 2018 but then slightly improved from 2018 to 2019.

Segment Capital Expenditures to Depreciation: Pharmaceutical Wholesale

Walgreens Boots Alliance Inc.; Pharmaceutical Wholesale; segment capital expenditures to depreciation calculation

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Selected Financial Data (US$ in millions)
Capital expenditures 104 104 107 104 51
Depreciation and amortization 150 155 150 166 120
Segment Financial Ratio
Segment capital expenditures to depreciation1 0.69 0.67 0.71 0.63 0.43

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).

1 2019 Calculation
Segment capital expenditures to depreciation = Capital expenditures ÷ Depreciation and amortization
= 104 ÷ 150 = 0.69

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Pharmaceutical Wholesale Pharmaceutical Wholesale segment capital expenditures to depreciation ratio deteriorated from 2017 to 2018 but then improved from 2018 to 2019 not reaching 2017 level.

Sales

Walgreens Boots Alliance Inc., sales by reportable segment

US$ in millions

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Retail Pharmacy USA 104,532 98,392 87,302 83,802 80,974 76,392
Retail Pharmacy International 11,462 12,281 11,813 13,256 8,781
Pharmaceutical Wholesale 23,053 23,006 21,188 22,571 15,327
Eliminations (2,181) (2,142) (2,089) (2,278) (1,638)
Total 136,866 131,537 118,214 117,351 103,444 76,392

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).


Adjusted operating income

Walgreens Boots Alliance Inc., adjusted operating income by reportable segment

US$ in millions

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Retail Pharmacy USA 5,255 5,814 5,606 5,357 5,098 4,866
Retail Pharmacy International 747 929 939 1,155 616
Pharmaceutical Wholesale 939 936 922 708 450
Eliminations 1 (12) (7)
Total 6,942 7,679 7,467 7,208 6,157 4,866

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).


Depreciation and amortization

Walgreens Boots Alliance Inc., depreciation and amortization by reportable segment

US$ in millions

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Retail Pharmacy USA 1,459 1,196 1,090 1,134 1,217 1,316
Retail Pharmacy International 429 419 414 401 393
Pharmaceutical Wholesale 150 155 150 166 120
Eliminations 17 12
Total 2,038 1,770 1,654 1,718 1,742 1,316

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).


Capital expenditures

Walgreens Boots Alliance Inc., capital expenditures by reportable segment

US$ in millions

Microsoft Excel
Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Retail Pharmacy USA 1,323 1,022 860 777 951 1,106
Retail Pharmacy International 275 241 384 444 249
Pharmaceutical Wholesale 104 104 107 104 51
Total 1,702 1,367 1,351 1,325 1,251 1,106

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).